Rebound Pain and Related Factors in Patients Who Underwent Femoral Nerve Block for Postoperative Pain Control in Total Knee Arthroplasty
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 150
- Locations
- 1
- Primary Endpoint
- Visual Analogue Scale
Study Overview
Brief Summary
The aim of this prospective observational study is to detect rebound pain and related factors in postoperative patients with total knee arthroplasty.
Detailed Description
Total knee arthroplasty is an effective treatment method for knee osteoarthritis and because it is an invasive method, more than 50% of patients experience postoperative pain. Peripheral nerve blocks are widely used for optimal pain control. The femoral block is a frequently preferred peripheral nerve block method for postoperative analgesia in total knee arthroplasty surgery. However, after peripheral nerve block, a condition called rebound pain (rebound pain), which is described as very severe pain, lasting about 2 hours, usually of the burning type, occurs. The aim of this prospective observational study is to detect rebound pain and related factors in postoperative patients with total knee arthroplasty.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •18-80 years older age who underwent total knee arthroplasty
Exclusion Criteria
- •ASA score 4 or >4
- •Active infection
- •End stage organ failure
- •Pregnancy
- •Established diagnosis neuropsychiatric disease ( epilepsy, neuropathy, neuromuscular disease, cerebrovascular disease...)
- •Uses of oral corticosteroids
Outcomes
Primary Outcomes
Visual Analogue Scale
Time Frame: postoperative 3-5 days fellow-up
The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').
Secondary Outcomes
No secondary outcomes reported
Investigators
Bilal Katipoglu
M.D
Gulhane Training and Research Hospital
